CN Patent
CN115785154B — 杂芳环化合物及其医药用途
Assigned to Siegershenko Shenzhen Co ltd · Expires 2025-09-05 · 1y expired
What this patent protects
本发明涉及一种杂环芳环化合物及其应用。具体地,所述杂环芳环化合物具有式0所示结构,各符号的定义如说明书所限定。该杂环芳环化合物对YAP具有较好的抑制作用。
USPTO Abstract
本发明涉及一种杂环芳环化合物及其应用。具体地,所述杂环芳环化合物具有式0所示结构,各符号的定义如说明书所限定。该杂环芳环化合物对YAP具有较好的抑制作用。
Drugs covered by this patent
- Alunbrig (brigatinib) · Takeda
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.